Literature DB >> 18617066

Functional recovery after acute myocardial infarction: comparison between angiography, electrocardiography, and cardiovascular magnetic resonance measures of microvascular injury.

Robin Nijveldt1, Aernout M Beek, Alexander Hirsch, Martin G Stoel, Mark B M Hofman, Victor A W M Umans, Paul R Algra, Jos W R Twisk, Albert C van Rossum.   

Abstract

OBJECTIVES: We examined the relation between angiographic, electrocardiographic, and gadolinium-enhanced cardiovascular magnetic resonance (CMR) characteristics of microvascular obstruction (MVO), and their predictive value on functional recovery after acute myocardial infarction (AMI).
BACKGROUND: Microvascular obstruction on CMR has been shown to predict left ventricular (LV) remodeling, but it is not well known how it compares with commonly used criteria of microvascular injury, and earlier reports have produced conflicting results on the significance and extent of MVO.
METHODS: Thrombolysis In Myocardial Infarction (TIMI) flow grade, myocardial blush grade (MBG), and ST-segment resolution were assessed in 60 patients with AMI treated with primary stenting. Cardiovascular magnetic resonance was performed between 2 and 9 days after revascularization to determine early MVO on first-pass perfusion imaging, late MVO on late gadolinium-enhanced imaging, and infarct size and transmural extent. Cine imaging was used to determine LV volumes and global and regional function at baseline and 4-month follow-up.
RESULTS: Early and late MVO were both related to incomplete ST-segment resolution (p = 0.002 and p = 0.01, respectively), but not to TIMI flow grade and MBG. Of all angiographic, electrocardiographic, and CMR variables, late MVO was the strongest parameter to predict changes in end-diastolic volume (beta = 0.53; p = 0.001), end-systolic volume (beta = 8.67; p = 0.001), and ejection fraction (beta = 3.94; p = 0.006) at follow-up. Regional analysis showed that late MVO had incremental diagnostic value to transmural extent of infarction (odds ratio: 0.18; p < 0.0001).
CONCLUSIONS: In patients after revascularized AMI, late MVO proved a more powerful predictor of global and regional functional recovery than all of the other characteristics, including transmural extent of infarction.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18617066     DOI: 10.1016/j.jacc.2008.04.006

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


  80 in total

Review 1.  Established and emerging cardiovascular magnetic resonance techniques for the assessment of stable coronary heart disease and acute coronary syndromes.

Authors:  David P Ripley; Manish Motwani; Sven Plein; John P Greenwood
Journal:  Quant Imaging Med Surg       Date:  2014-10

2.  Relationship and prognostic value of microvascular obstruction and infarct size in ST-elevation myocardial infarction as visualized by magnetic resonance imaging.

Authors:  Suzanne de Waha; Steffen Desch; Ingo Eitel; Georg Fuernau; Philipp Lurz; Anja Leuschner; Matthias Grothoff; Matthias Gutberlet; Gerhard Schuler; Holger Thiele
Journal:  Clin Res Cardiol       Date:  2012-06       Impact factor: 5.460

3.  Head to head comparison of quantitative versus visual analysis of contrast CMR in the setting of myocardial stunning after STEMI: implications on late systolic function and patient outcome.

Authors:  Oliver Husser; Vicente Bodi; Juan Sanchis; Julio Nunez; Luis Mainar; Pilar Merlos; Maria P Lopez-Lereu; Jose V Monmeneu; Fabian Chaustre; Eva Rumiz; Günter A J Riegger; Francisco J Chorro; Angel Llacer
Journal:  Int J Cardiovasc Imaging       Date:  2010-02-20       Impact factor: 2.357

4.  Cardiac magnetic resonance derived late microvascular obstruction assessment post ST-segment elevation myocardial infarction is the best predictor of left ventricular function: a comparison of angiographic and cardiac magnetic resonance derived measurements.

Authors:  Dennis T L Wong; Michael C H Leung; James D Richardson; Rishi Puri; Angela G Bertaso; Kerry Williams; Ian T Meredith; Karen S L Teo; Matthew I Worthley; Stephen G Worthley
Journal:  Int J Cardiovasc Imaging       Date:  2012-02-05       Impact factor: 2.357

Review 5.  Targeting angiogenesis to restore the microcirculation after reperfused MI.

Authors:  Anja M van der Laan; Jan J Piek; Niels van Royen
Journal:  Nat Rev Cardiol       Date:  2009-06-16       Impact factor: 32.419

6.  Timing of cardiovascular MR imaging after acute myocardial infarction: effect on estimates of infarct characteristics and prediction of late ventricular remodeling.

Authors:  Adam N Mather; Timothy A Fairbairn; Nigel J Artis; John P Greenwood; Sven Plein
Journal:  Radiology       Date:  2011-08-09       Impact factor: 11.105

Review 7.  Post myocardial infarction of the left ventricle: the course ahead seen by cardiac MRI.

Authors:  Pier Giorgio Masci; Jan Bogaert
Journal:  Cardiovasc Diagn Ther       Date:  2012-06

8.  Peri-infarct ischaemia assessed by cardiovascular MRI: comparison with quantitative perfusion single photon emission CT imaging.

Authors:  E Gerbaud; H Cochet; E Bullier; C Ragot; S H Gilbert; H Douard; Y Pucheu; F Laurent; P Coste; L Bordenave; M Montaudon
Journal:  Br J Radiol       Date:  2014-04-29       Impact factor: 3.039

9.  Investigation of T2-weighted signal intensity of infarcted myocardium and its correlation with delayed enhancement magnetic resonance imaging in a porcine model with reperfused acute myocardial infarction.

Authors:  Seong Hoon Choi; Joon-Won Kang; Sang-Tae Kim; Byung Han Lee; Eun Ju Chun; Karl H Schuleri; Sang Il Choi; Tae-Hwan Lim
Journal:  Int J Cardiovasc Imaging       Date:  2009-01-28       Impact factor: 2.357

10.  Appearance of microvascular obstruction on high resolution first-pass perfusion, early and late gadolinium enhancement CMR in patients with acute myocardial infarction.

Authors:  Adam N Mather; Timothy Lockie; Eike Nagel; Michael Marber; Divaka Perera; Simon Redwood; Aleksandra Radjenovic; Ansuman Saha; John P Greenwood; Sven Plein
Journal:  J Cardiovasc Magn Reson       Date:  2009-08-21       Impact factor: 5.364

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.